ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Processa Pharmaceuticals Inc

Processa Pharmaceuticals Inc (PCSA)

1.68
0.04
( 2.44% )
Updated: 13:05:21

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Key stats and details

Current Price
1.68
Bid
1.67
Ask
1.69
Volume
8,109
1.63 Day's Range 1.69
1.40 52 Week Range 18.00
Market Cap
Previous Close
1.64
Open
1.63
Last Trade
1
@
1.69
Last Trade Time
14:00:15
Financial Volume
$ 13,560
VWAP
1.6723
Average Volume (3m)
101,822
Shares Outstanding
2,858,007
Dividend Yield
-
PE Ratio
-0.43
Earnings Per Share (EPS)
-3.89
Revenue
-
Net Profit
-11.12M

About Processa Pharmaceuticals Inc

Processa Pharmaceuticals Inc is a clinical-stage biopharmaceutical company based in the United States. It focuses on the development of drug products that are intended to improve the survival and quality of life for patients who have an unmet medical need. The company's lead product, PCS499 is an or... Processa Pharmaceuticals Inc is a clinical-stage biopharmaceutical company based in the United States. It focuses on the development of drug products that are intended to improve the survival and quality of life for patients who have an unmet medical need. The company's lead product, PCS499 is an oral tablet that is an analog of an active metabolite of an already approved drug. It focuses on fibrotic related diseases such as focal segmental glomerulosclerosis, idiopathic pulmonary fibrosis. Its pipeline products comprise PCS6422, PCS12852, and PCS100. Show more

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Headquarters
Wilmington, Delaware, USA
Founded
1970
Processa Pharmaceuticals Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker PCSA. The last closing price for Processa Pharmaceuticals was $1.64. Over the last year, Processa Pharmaceuticals shares have traded in a share price range of $ 1.40 to $ 18.00.

Processa Pharmaceuticals currently has 2,858,007 shares outstanding. The market capitalization of Processa Pharmaceuticals is $4.69 million. Processa Pharmaceuticals has a price to earnings ratio (PE ratio) of -0.43.

PCSA Latest News

Processa Pharmaceuticals Names Russell L. Skibsted as Chief Financial Officer

HANOVER, Md., July 17, 2024 (GLOBE NEWSWIRE) -- Processa Pharmaceuticals, Inc. (Nasdaq: PCSA) (Processa or the Company), a clinical-stage pharmaceutical company focused on developing the next...

Processa Pharmaceuticals Announces Positive Efficacy Results from Preliminary Evaluation of Phase 1b Dose-escalating Trial with NGC-Cap in Gastrointestinal Cancer

Eight of 12 evaluable patients (66.7%) had progression-free survival (PFS) rangingย from 5 to 11 months At the highest NGC-Cap dose, all three evaluable patients had PFS with two partial responses...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.05-2.89017341041.731.80071.6355501.6696872CS
4-0.29-14.72081218271.972.241.6362101.79278541CS
12-0.4-19.23076923082.082.5941.421018221.92330215CS
26-0.73-30.29045643152.415.90991.414962163.52891619CS
52-6.08-78.35051546397.76181.416177396.36941164CS
156-138.32-98.8140179.8141.459239410.04405406CS
260-74.32-97.789473684276284.7981.447946914.14927164CS

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
DCAPUnity Wealth Partners Dynamic Capital Appreciation & Options ETF
 20.10
(839.25%)
128.77k
RGCRegencell Bioscience Holdings Ltd
$ 17.91
(431.45%)
574.2k
SLRXSalarius Pharmaceuticals Inc
$ 3.31
(114.94%)
56.26M
ATPCAgape ATP Corporation
$ 0.234101
(63.71%)
99.3M
CJETChijet Motor Company Inc
$ 5.02
(53.52%)
337.3k
FLYEFly E Group Inc
$ 1.2195
(-80.89%)
15.99M
RNAZTransCode Therapeutics Inc
$ 0.30
(-62.15%)
7.89M
JAGXJaguar Health Inc
$ 1.808
(-57.66%)
14.05M
MIRAMIRA Pharmaceuticals Inc
$ 2.5897
(-48.31%)
23.47M
SLNASelina Hospitality PLC
$ 0.025
(-32.43%)
122.7M
SPWRSunPower Corporation
$ 1.0826
(51.24%)
158.75M
ADILAdial Pharmaceuticals Inc
$ 1.45
(36.79%)
155.66M
SLNASelina Hospitality PLC
$ 0.025
(-32.43%)
122.7M
NVDANVIDIA Corporation
$ 122.8798
(-0.53%)
119.87M
ATPCAgape ATP Corporation
$ 0.234101
(63.71%)
99.3M

PCSA Discussion

View Posts
valleybenedetto valleybenedetto 1 month ago
News is excellent but with a $50 million shelf and the way they alienated retail with the reverse split and immediate offering they are getting a very limited response to what should be gangbuster news
๐Ÿ‘๏ธ0
02opida 02opida 1 month ago
HANOVER, MD., June 11, 2024 (GLOBE NEWSWIRE) -- Processa Pharmaceuticals, Inc. (Nasdaq: PCSA) (Processa or the Company), a clinical-stage pharmaceutical company focused on developing the next generation of chemotherapeutic drugs with improved efficacy and safety, today announced positive efficacy results from the preliminary evaluation of its recently completed Phase 1b clinical trial which defined the Maximum Tolerated Dose (MTD) and Recommended Phase 2 Dose Range (RP2DR) for Next Generation Capecitabine (NGC-Cap) administered to patients with Stage III or IV gastrointestinal tract (GI) cancer.

โ€œWe are encouraged by the preliminary efficacy analysis from our NGC-Cap Phase 1b dose-escalating safety/tolerability trial demonstrating some anti-tumor activity in patients with advanced GI cancer who have progressive cancer after relapsing or not responding to prior therapy. The favorable response is likely due to NGC-Capโ€™s ability to distribute more 5-FU to cancer cells than monotherapy capecitabine. The promising Phase 1b safety and tolerability profile plus these early efficacy signals provide validation for further development of NGC-Cap,โ€ stated David Young, PharmD, Ph.D., President of Research and Development at Processa. โ€œFrom this Phase 1b trial, we have been able to define the MTD and the RP2DR to use in our Phase 2 Optimal Dosage Regimen trial in breast cancer in the third quarter of 2024.โ€

Dr. Young added, โ€œGiven the need for more effective chemotherapy treatment with improved tolerability across multiple types of cancer, we believe that NGC-Cap has the potential to provide a safer, more efficacious option to treat the different cancers for which capecitabine and 5-FU are presently used.โ€

The NGC-Cap Phase 1b trial is evaluating ascending doses of capecitabine when administered after a single dose of PCS6422 in Stage III or IV patients with advanced, relapsed or refractory progressive GI cancer. All patients relapsed from or failed all other treatments, including prior treatment with capecitabine or 5-FU. For all doses of capecitabine in the Phase 1b NGC-Cap trial, exposure to 5-FU was greater and exposure to FBAL was lower with a better or similar side effect profile compared with monotherapy capecitabine. In addition, preliminary analysis of the efficacy data demonstrated early evidence of anti-tumor activity of capecitabine combined with PCS6422, which was assessed using RECIST 1.1 evaluations (Response Evaluation Criteria in Solid Tumors) by scans every eight weeks.
๐Ÿ‘๏ธ0
valleybenedetto valleybenedetto 2 months ago
50m shelf. Company is run by morons. Short it
๐Ÿ‘๏ธ0
02opida 02opida 3 months ago
nice chart
๐Ÿ‘๏ธ0
Monksdream Monksdream 3 months ago
No 1 on the Barchart 100
https://www.barchart.com/stocks/performance/percent-change/advances?timeFrame=today&viewName=main&screener=overall&orderBy=percentChange&orderDir=desc
๐Ÿ‘๏ธ0
Awl416 Awl416 3 months ago
Processa Pharmaceuticals Presents Two Abstracts at the AACR Annual Meeting 2024 Including New Data on the NGC-Cap Phase 1b Trial
๐Ÿ‘๏ธ0
Monksdream Monksdream 4 months ago
PCSA under $3
๐Ÿ‘๏ธ0
valleybenedetto valleybenedetto 5 months ago
https://www.secform4.com/insider-trading/1533743.htm
More insider buying
๐Ÿ‘๏ธ0
valleybenedetto valleybenedetto 6 months ago
I love retarded posts like this.
๐Ÿ‘๏ธ0
Sweetleaf Sweetleaf 6 months ago
LOL.. this is total garbage. Going under a dollar and then will reverse split again to eliminate current stock holders and start all over.
๐Ÿ‘๏ธ0
Muhbruh Muhbruh 6 months ago
bullish
$PCSA Bottom chart 2.6M float Offering closed yesterday
Recent r/s name with 3 Insider buys this week and upcoming catalyst pic.twitter.com/QZjt346W0f— STOCKS Gambino (@StocksGambino) February 2, 2024
๐Ÿ‘๏ธ0
Sweetleaf Sweetleaf 6 months ago
OFFERING CLOSED... STILL NO MOVEMENT PRESS RELEASE OUT 1 HOUR AGO.
๐Ÿ‘๏ธ0
valleybenedetto valleybenedetto 6 months ago
Form 4 insider buys just hit.
๐Ÿ‘๏ธ0
Bud-Wiser Bud-Wiser 6 months ago
Offering now closed-8k
๐Ÿ‘๏ธ0
Bud-Wiser Bud-Wiser 6 months ago
Gonna get interesting when/if we get the filing that the offering is done
๐Ÿ‘๏ธ0
Bud-Wiser Bud-Wiser 6 months ago
Curling up off the lows
๐Ÿ‘๏ธ0
TheFinalCD TheFinalCD 6 months ago
please post the spectacular chart, so we can all see
๐Ÿ‘๏ธ0
Bud-Wiser Bud-Wiser 6 months ago
Chart now looks spectacular. Iโ€™m fully loaded here ready for the next pop. I know itโ€™s gonna be 5 -6 or seven bucks.
๐Ÿ‘๏ธ0
valleybenedetto valleybenedetto 6 months ago
💪👍
๐Ÿ‘๏ธ0
Bud-Wiser Bud-Wiser 6 months ago
Nice โ€ฆme too
๐Ÿ‘๏ธ0
valleybenedetto valleybenedetto 6 months ago
PALI fell off a cliff too. I just grabbed a bit more PCSA here. Will continue to add now that all bad news is out of the way.
๐Ÿ‘๏ธ0
TheFinalCD TheFinalCD 6 months ago
PCSA 2.52 missed that,
was too busy with PALI FRSX SOFI
๐Ÿ‘๏ธ0
TheFinalCD TheFinalCD 6 months ago
yep I should have stayed away when I sold for profit
๐Ÿ‘๏ธ0
valleybenedetto valleybenedetto 6 months ago
Company did everything in their power to ensure that happened. Very poorly managed.
๐Ÿ‘๏ธ0
TrendTrade2016 TrendTrade2016 6 months ago
Remember the clowns that didnโ€™t believe me
On the pre split crash
๐Ÿ‘๏ธ0
valleybenedetto valleybenedetto 6 months ago
Predictable but this should be at or close to bottom.
๐Ÿ‘๏ธ0
valleybenedetto valleybenedetto 6 months ago
Sure thing. His name is Patrick Lin fyi.
๐Ÿ‘๏ธ0
TrendTrade2016 TrendTrade2016 6 months ago
Ouch that hurts
๐Ÿ‘๏ธ0
TheFinalCD TheFinalCD 6 months ago
oh good to know, thanks for reaching out
๐Ÿ‘๏ธ0
Bud-Wiser Bud-Wiser 6 months ago
Perfectโ€ฆthanks
๐Ÿ‘๏ธ0
valleybenedetto valleybenedetto 6 months ago
Just spoke to CFO . NOT NEW. Effective on pricing. No new offering.
๐Ÿ‘๏ธ0
TheFinalCD TheFinalCD 6 months ago
yep I took it as new, why would they file effective after they already offered?

thats putting the horse b4 the carriage right?
๐Ÿ‘๏ธ0
valleybenedetto valleybenedetto 6 months ago
Just not sure if it's previous offering or a new one. That makes quite a difference.
๐Ÿ‘๏ธ0
TheFinalCD TheFinalCD 6 months ago
thats why I posted and was surprised you bought after

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=173723139
๐Ÿ‘๏ธ0
valleybenedetto valleybenedetto 6 months ago
If it's a new offering this thing is dead
๐Ÿ‘๏ธ0
TheFinalCD TheFinalCD 6 months ago
MY NEW AVG UNDER $3 NOW

BUT HOPEFULLY OUT ON BOUNCE
๐Ÿ‘๏ธ0
TheFinalCD TheFinalCD 6 months ago
effectiveness OF DILUTION
๐Ÿ‘๏ธ0
valleybenedetto valleybenedetto 6 months ago
Need to find out what the notice of effectiveness is for.
๐Ÿ‘๏ธ0
Bud-Wiser Bud-Wiser 6 months ago
Just bought 1000 more share $2.75
๐Ÿ‘๏ธ0
valleybenedetto valleybenedetto 6 months ago
Ugly knife...yuck
๐Ÿ‘๏ธ0
valleybenedetto valleybenedetto 6 months ago
I'm expecting insider buys. I'm sure they participated in the offering. Additional news will send it back to the 5s
๐Ÿ‘๏ธ0
TheFinalCD TheFinalCD 6 months ago
lol dont stop now....its right @ my new average 3.35

after buying all the way down to 2.93
๐Ÿ‘๏ธ0
valleybenedetto valleybenedetto 6 months ago
There's the turn. Nice
๐Ÿ‘๏ธ0
TheFinalCD TheFinalCD 6 months ago
Form EFFECT - Notice of Effectiveness
January 29 2024 - 12:15AM
Edgar (US Regulatory)
๐Ÿ‘๏ธ0
valleybenedetto valleybenedetto 6 months ago
Just took some 2.99/3.00s..should turn
๐Ÿ‘๏ธ0
TheFinalCD TheFinalCD 6 months ago
2.93 GRRRR
๐Ÿ‘๏ธ0
TheFinalCD TheFinalCD 6 months ago
PCSA 3.31

I SHOULD HAVE JUST SOLD ALL ON FRI

SIGH
๐Ÿ‘๏ธ0
Bud-Wiser Bud-Wiser 6 months ago
Time to let these Dogs Hunt-after-hours
๐Ÿ‘๏ธ0
Bud-Wiser Bud-Wiser 6 months ago
Starting to move up.330 pm is here. I sold 800 share increments Pre Market three different times starting at like 585 and then 597 and then I think 612. Kept 600 shares went and made myself an iced coffee and came back and she was in the 4โ€™s. I got out with about 12 to 15 minutes to spare. Got stuck with 800 shares at my original average of under 5
๐Ÿ‘๏ธ0
TheFinalCD TheFinalCD 6 months ago
ok my avg is 3.74 have sell set @ 4.07
-LOL
๐Ÿ‘๏ธ0

Your Recent History

Delayed Upgrade Clock